PE  Linden

http://www.lindenllc.com





     Office Locations:

150 N Riverside Plaza, Suite 5100
Chicago, IL 60606
Phone: 312-506-5600
Fax: 312-506-5601

 

Stages:

  • Middle Market


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    Formed in 2002, Linden is a healthcare and life sciences private equity firm that builds value in mature businesses. Linden's investment strategy is to purchase controlling equity interests in privately held companies and non-core businesses that can benefit from strategic redirection, operational improvements, acquisitions and additions to the management team. Linden invests primarily in leveraged buyouts or other late-stage transactions where it can be the lead investor or otherwise have significant governance influence. Linden does not make venture capital investments. Currently, Linden manages $1.3 billion in assets augmented by capital provided by their Limited Partners for larger transactions. To invest in mature companies of all sizes, Linden formed an alliance with Madison Dearborn Partners (see profile) to pursue large healthcare and life science buyout transactions (transactions requiring more than $50 million in private equity capital). Linden pursues smaller transactions (requiring less than $50 million in private equity capital) using its own funds.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Anthony B. Davis Managing Partner and President
    Brian C. Miller Managing Partner
    Douglass W. VanDegrift CFO and CCO
    Joshua M. Reilly VP
    Kam N. Shah Principal

     

    Portfolio companies include:


      BarrierSafe Solutions
        web link


      Behavioral Centers of America
        web link


      Chesapeake IRB
        web link


      Corpak Medsystems
        web link


      Drayer Physical Therapy
        web link


      Flexan
        web link


      Focused Health Solutions
        web link


      Gentle Dental
        web link


      Hycor
        web link


      HydraFacial Co
        web link


      MeriCal
        web link


      Pinnacle Treatment Centers
        web link


      ProPharma Group
        web link


      Ranir
        web link


      SeraCare
        web link


      Spear
        web link


      Strata Pathology
        web link


      Suture Express
        web link


      Virtus Pharmaceuticals
        web link


      Young Innovations
        web link


     

    Recent News: